Differential Expression of Intracellular Apoptotic Signaling Molecules in Tumor and Tumor-Infiltrating Lymphocytes during Development of Invasion and/or Metastasis of Gastric Carcinoma

Digestive Diseases and Sciences

Volumn 48, Issue 12, 2003, Pages 2290-2300

  Koyama, Shohei ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Caspase 3; Caspase 8; cFLIP; Gastric carcinoma; NF B; Survivin

Indexed keywords

CASPASE 10; CASPASE 3; CASPASE 8; CELL ADHESION MOLECULE; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; SURVIVIN;

ADULT; AGED; APOPTOSIS; ARTICLE; ASCITES; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STOMACH CARCINOMA; STOMACH EPITHELIUM; STOMACH MUCOSA; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 10; CASPASE 8; CASPASE 9; CASPASES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NF-KAPPA B; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 0346433670     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000007865.96569.9a     Document Type: Article

References (41)

1. Nagata S: Apoptosis by death factor. Cell 88:355-365, 1997
2. Ashkenazi A, Dixit VM: Death receptors: signaling and modulation. Science 281:1305-1308, 1998
3. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammaer PH, Peter ME, Dixit VM: FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex. Cell 85:817-827, 1996
4. Vincenz C, Dixit VM: Fas-associated death domain protein interleukin-1 beta-converting enzyme 2 (FLICE 2), an ICE/çed-3 homologue, is proximally involved in CD95-and p55-mediated death signaling. J Biol Chem 272:6578-6583, 1997
5. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 326:1-16, 1997
6. Muzio M, Stockwell BR, Stennicke HR, Salvensen GS, Dixit VM: An induced proximity model for caspase-8 activation. J Biol Chem 273:2926-2930, 1998
7. Bodmer J-L, Holler N, Reynard S, Vinciguerra P, Schneider P, Juo P, Blenis J, Tschopp J: TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nature Cell Biol 2:241-243, 2000
8. Kuang AA, Diehl GE, Zhang J, Winoto A: FADD is required for DR4 and DR5-mediated apoptosis. J Biol Chem 275:25065-25068. 2000
9. Eggert A, Grotzer MA, Zuzak TJ, Wiewrodt BR, Ho R, Ikegami N, Brodeur GM: Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Cancer Res 61:1314-1319, 2001
10. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK. Sutherland GR, Davis Smith T, Rauch C, Smith CA, Goodwin RG: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682, 1995
11. Sheridan JP, Marsters SA, Pitti RM, GL, Gurney A, Skubatch A, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A: Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277:818-821, 1997
12. Koyama S, Koike N, Adachi S: Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape by gastric carcinoma. J Cancer Res Clin Oncol 127:20-26, 2001
13. Koyama S, Koike N, Adachi S: Expression of TNF-related apoptosis inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor. J Cancer Res Clin Oncol 128:73-79, 2002
14. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer J-L, Schröter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp T: Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195, 1997
15. Hu S, Vincenz C, Ni J, Gentz R, Dixit VM: I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD95-induced apoptosis. J Biol Chem 272:17255-17257, 1997
16. Ambrosini G, Adida C, Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Med 3:917-921, 1997
17. Tamm I, Wang Y, Sausville ED, Scudiero DA, Vigna N, Oltersdorf T, Reed JC: IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspase, and anticancer drugs. Cancer Res 58:5315-5320, 1998
18. Lu C-D, Altieri DC, Tanigawa N: Expression of a novel antiapoptotic gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58:1808-1812, 1998
19. Okada E, Murai Y, Matsui K, Ishizawa S, Cheng C, Masuda M, Takano Y: Survivin expression in tumor cell nuclei of a favorable prognosis in gastric cancer patients. Cancer Lett 163:109-116, 2001
20. Krieg A, Mahotka C, Krieg T, Grabsch H, Müller W, Takeno S, Suschek CV, Heydthausen M, Gabbert HE, Gerharz CD: Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumor progression. Br J Cancer 86:737-743, 2002
21. Baeuerle PA, Baltimore D: NF-κB: Ten years after. Cell 87:13-20, 1996
22. Wang C-Y, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS: Jr NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 suppress caspase-8 activation. Science 281:1680-1683, 1998
23. Huang S, DeGuzman A, Bucana CD, Fidler IJ: Nuclear factor-κB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. Clin Cancer Res 6:2573-2581, 2000
24. Rayet B, Gélinas C: Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18:6938-6947, 1999
25. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J: NF-κB signals induce the expression of c-FLIP. Mol Cell Biol 21:5299-5305, 2001
26. Deveraux QL, Reed JC: IAP family proteins - suppressors of apoptosis. Genes Dev 13:239-252, 1999
27. Koyama S, Maruyama T, Adachi S, Nozue M: Expression of costimulatory molecules, B7-1 and B7-2 on human gastric carcinoma. J Cancer Res Clin Oncol 124:383-388, 1998
28. Koyama S, Maruyama T, Adachi S: Expression of epidermal growth factor receptor and CD44 splicing variants sharing exsons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis. J Cancer Res Clin Oncol 125:47-54, 1999
29. Koyama S: Apoptotic depletion of infiltrating mucosal lymphocytes associated with Fas ligand expression by Helicobacter pylori-infected gastric mucosal epithelium: human glandular stomach as a site of immune privilege. Dig Dis Sci 45:773-780, 2000
30. Koyama S: Flow cytometric measurement of tumor necrosis factor-related apoptosis inducing ligand and its receptors in gastric epithelium and infiltrating mucosal lymphocytes in Helicobacter pylori-associated gastritis. J Gastroenterol Hepatol 18:763-770, 2003
31. Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma, 2nd English ed. Gastric Cancer 1:10-24, 1998
32. Tepper CG, Seldin M: Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of Epstein-Barr virus tumorigenesis in Burkitt's lymphoma. Blood 94:1727-1737, 1999
33. Griffith TS, Chin WA, Jackson GC, Lynch DH, Kubin MZ: Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol 161:2833-2840, 1998
34. Leverkus M, Neumann M, Mengling T, Rauch CT, Bröcker E-B, Krammer PH, Walczak H: Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. Cancer Res 60:553-559, 2000
35. Medema JP, de Jong J, van Hall T, Melief CJM, Offringa R: Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein. J Exp Med 190:1033-1038, 1999
36. Gilmore T, Gapuzan M-E, Kalaitzidis D, Starczynowski D: Rel/NF-κB/IκB signal transduction in the generation and treatment of human cancer. Cancer Lett 181:1-9, 2002
37. Sasaki N, Morisaki T, Hashizume K, Yao T, Tsuneyoshi M, Noshiro H, Nakamura K, Yamanaka T, Uchiyama A, Tanaka M, Katano M: Nuclear factor-κB p65 (ReIA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 7:4136-4142, 2001
38. Franco AV, Zhang XD, Berkel EV, Sanders JE, Zhang XY, Thomas WD, Nguyen T, Hersey P: The role NF-κB in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells. J Immunol 166:5337-5345, 2001
39. Trauzold A, Wermann H, Arlt A, Schütze S, Schäfer H, Oestern S, Röder C, Ungefroren H, Lampe E, Heinrich M, Walczak H, Kalthroff H: CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-κB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells. Oncogene 20:4258-4269, 2001
40. Oya M, Ohtsubo M, Takayanagi A, Tachibana M, Shimizu N, Murai M: Constitutive activation of nuclear factor-κB prevents TRAIL-induced apoptosis in renal cancer cells. Oncogene 20:3888-3896, 2001
41. Huang S, Pettaway CA, Uehara H, Bucana CD, Fidler IJ: Blockade of NF-κB activity in human prostate cancer cell lines is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 20:4188-4197, 2001